Skip to content
CED Clinic
Contact Us Book Consultation GLP-1 Care
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
  • Facebook
  • X
  • Email
  • Instagram
  • YouTube
  • Substack
  • Dr Caplan’s Book
CED Clinic CED Clinic CED Clinic

Medicinal cannabis is changing the face of clinical medicine. We are the leaders of that change.

CED Clinic CED Clinic CED Clinic

Medicinal cannabis is changing the face of clinical medicine. We are the leaders of that change.

  • 📍 Main Menu
    • Home
    • CED Clinic Heart: Our Values
    • Learn More: CED Clinic
    • Contact us
      • Leave a Message
      • Request Telemedicine Visit
    • Meet Dr. Caplan
      • Dr Caplan on Social Media
      • Dr Caplan's Substack
      • Dr Caplan's Podcast
      • Dr Caplan's Book: Doctor-Approved Cannabis Handbook
    • Meet Erin Caplan, NP
    • Ask Dr Caplan (public Q&A)
    • Discussion Forums
    • SiteMap
  • Patient Care
    • New Patients - Welcome!
      • Book a Virtual Appointment
      • Intake Form
      • How to Get a Medical Marijuana Card (in MA)
      • Qualifying Conditions
      • Ailments That Cannabis Treats
      • Testimonials
      • Patient Stories
      • Adult Cannabis Care
      • Autism, Behavior & Language Help
    • Before & After Apppointments
      • Request a Virtual Visit
      • Your Cannabis Journey
      • Your First Visit
      • Registration Information
      • Caregiver Information
      • After Registration
      • Which Products Are For You?
    • Cannabis & Seniors
      • 💜 Caregiver Support for Seniors
      • Seniors & Healthy Aging
      • Support for Caregiver of Seniors
      • Cannabis & Seniors: A New Chapter in Comfort
      • Cancer & Terminal Illness Support
      • End-of-Life Planning
      • Blog: Rising Cannabis Use in Older Adults
    • Pediatrics & Adolescents
      • Pediatric Care at CED Clinic
      • Pediatrics: Safety, Evidence & Risks
      • Cannabis for Young People: FAQ
      • 5 Benefits of Pediatric Cannabis Certification
      • Learn about Pedi & Adolescent Care
      • 10 Ways Cannabis Supports Children’s Behavior
      • Children & Behavior Support
      • Safe Dosing for Kids
      • Complex Pediatric Care
    • Sponsor a Visit (Give a Gift of Care)
    • Discounts at CED
      • Lottery for a Free Consultation
      • Discounts, Coupons, and Free Consultations
      • Discounts at Dispensaries (MA)
    • GLP-1 Weight Management
    • Health Quiz: Are You Healthy?
  • Education
    • Practical Tips + Guidance
      • Travel With Cannabis
      • COA Guide & Lab Safety
      • Fixing Your Cannabis Tolerance
      • Why Cannabis Works
      • Smart Cannabis Dosing: Sweet Spot?
      • Cannabis Myths + Blind Spots
      • How to Talk to Your Doc about Cannabis
      • Slow Medicine: How Cannabis Heals Over Time
      • Why The War on Pot Rages
      • Feeling Too High?
      • Cannabis & Mental Health Truths
      • Cannabis Cough: The Basics
      • Science of The Cannabis Cough
      • What To Do: Feeling Too Racy
      • Weed Anxiety Explained: Paranoia, Panic & Relief
      • Why Aren’t Edibles Don't Work for You?
      • When to Pause
      • Cannabis Hyperemesis Syndrome (CHS): What to Know
    • Health & Wellness
      • Cannabis & Health (general)
      • Choosing Cannabis
      • Tips for Maximizing Effectiveness
      • Cannabis & Metabolism: Be Amazed!
      • Cannabis for Sleep
      • Cannabis for Stress
      • Cannabis for Pain
      • Topicals Guide
      • Future of Cannabis
    • Learn by Illness or Condition
      • Custom Cannabis Protocol
      • Mental Health & Neurological Disorders
      • ADHD: A Guide to Focus, Calm, and Control
      • Crohn’s and Gut Health: Relief Strategies
      • Gastrointestinal & Autoimmune Conditions
      • Dermatological & Skin Conditions
      • Chronic Pain & Inflammation
      • Women’s Health & Hormonal Conditions
      • Pregnancy & Cannabis, Explained
      • Sleep Disorders & Circadian Rhythm Issues
      • Pain Management with Cannabis
      • Autism & Behavior: Expert Guidance for Families
      • Post-Surgical & Injury Recovery
      • Substance Dependence & Withdrawal Support
    • Learn about Products
      • Types of Cannabis Sold
      • CBD Strength Guide
      • Cannabis Tolerance: Management
      • Topical Cannabis Products: Guide to Uses, Benefits & DIY
      • Unique Cannabinoids: Beyond THC & CBD
      • Vaporizing Cannabis: Safer, Effective Consumption
    • Best Ways To Take Cannabis
      • Cannabis FAQs (basic)
      • Start Here
      • Cannabis Therapy Guidance
      • Dosage & Usage Guide
      • Nebulized Cannabis Guide
      • Topicals & Lotions
      • Tinctures & Oils
      • Cannabis Edibles & Capsules
      • Inhalables & Vaporization
    • Educational Resources
      • Dr Caplan's Book Website
        • Personalized, Signed Copy
        • My Book (Amazon)
        • Each Book Dedication is Unique!
      • FAQ Encyclopedia
      • Dr Caplan's Classroom
        • Book Diagrams + CaplanCannabis Site (free)
        • Video Library
        • Handouts & Guides
        • AI Book Review
        • Spotify: Green Table Talk Podcast
        • YouTube
        • Dr Caplan's Book (Order Now - Amazon!)
      • Cannabis Basics Overview
      • The Problems Cannabis Helps Us Manage
      • Endocannabinoid System
      • Cannabis Science
      • CED Cannabis Literature Library
      • Patient Care & Findings
      • Patient Insights
    • Guide: How to Buy Cannabis Flower
    • FAQ (Cannabis Encyclopedia)
    • Popular Blogs: 2026
      • Long-Term Effects of Cannabis
      • Reset Your Cannabis Tolerance
      • Weed Anxiety Explained: A Doctor’s Guide to Paranoia, Panic & Relief
      • 5 Reasons CBD CBG Topicals For Eczema Care is Amazing
      • Cannabis for Sleep
      • Slow Medicine: How Cannabis Heals Over Time
      • Why Aren’t Edibles Working for You?
      • When Cannabis Might NOT Be Right for You
      • Women’s Health & Hormonal Conditions
      • Cannabis for Stress
      • Cannabis for ADHD: A Guide to Focus, Calm, and Control
      • Too High? What To Do
      • Moldy Marijuana: MA recalls moldy flower
    • CED Favorites
      • Video: Cannabis Tolerance Explained
      • Plant Nurition Explained
      • Light THC & CBD Picks
      • High-Potency Cannabis Guide
      • Sugar-Free Cannabis Options
      • Cannabis & Your Heart
      • Cannabis and Psychosis
      • Vaginal Suppositories Page
      • Rectal Suppositories Page
      • Medical Cannabis Crossroads
      • Cannabis and Heart Health
      • Is Weed Addictive? Dependence vs Addiction
      • Cannabis and Menopause
      • Cannabis & Aging
      • CBD & Liver Enzymes
      • How Cannabis Works Differently
      • Emergence: How Wholes Outthink Parts
      • Our New Post-Covid Baseline
    • Non-Cannabis Writing
      • Social Capacity vs Identity: Connection
      • AI in Medicine Explained
      • Tylenol & Autism Debate
      • Power of Clicks and Likes
      • Rethinking Diagnosis in Kids
  • Partner with Dr Caplan
    • Partner on Education & Research
    • Work with Dr Caplan
    • Media Inquiries
    • Interview Dr. Caplan
    • Book Dr. Caplan to Speak
    • Clinical Cannabis Education Program
    • Modular (Custom) Professional Education
    • Volunteer at CED (Social Impact Work)
    • Cannabis Business Consulting
    • Building Big Data
    • Promote With CED Clinic
  • Resources, Supplies, Events
    • Share YOUR Story
    • Trusted Resources & Products
    • Shop Products: Gummies, Drinks, Oils, Flower...
    • Handmade Glass
    • Myriams CBD
    • Outside Resources
    • Past Events
    • Dispensary Highlights
    • Fireside Chats
  • 📍 Main Menu
    • Home
    • CED Clinic Heart: Our Values
    • Learn More: CED Clinic
    • Contact us
      • Leave a Message
      • Request Telemedicine Visit
    • Meet Dr. Caplan
      • Dr Caplan on Social Media
      • Dr Caplan's Substack
      • Dr Caplan's Podcast
      • Dr Caplan's Book: Doctor-Approved Cannabis Handbook
    • Meet Erin Caplan, NP
    • Ask Dr Caplan (public Q&A)
    • Discussion Forums
    • SiteMap
  • Patient Care
    • New Patients - Welcome!
      • Book a Virtual Appointment
      • Intake Form
      • How to Get a Medical Marijuana Card (in MA)
      • Qualifying Conditions
      • Ailments That Cannabis Treats
      • Testimonials
      • Patient Stories
      • Adult Cannabis Care
      • Autism, Behavior & Language Help
    • Before & After Apppointments
      • Request a Virtual Visit
      • Your Cannabis Journey
      • Your First Visit
      • Registration Information
      • Caregiver Information
      • After Registration
      • Which Products Are For You?
    • Cannabis & Seniors
      • 💜 Caregiver Support for Seniors
      • Seniors & Healthy Aging
      • Support for Caregiver of Seniors
      • Cannabis & Seniors: A New Chapter in Comfort
      • Cancer & Terminal Illness Support
      • End-of-Life Planning
      • Blog: Rising Cannabis Use in Older Adults
    • Pediatrics & Adolescents
      • Pediatric Care at CED Clinic
      • Pediatrics: Safety, Evidence & Risks
      • Cannabis for Young People: FAQ
      • 5 Benefits of Pediatric Cannabis Certification
      • Learn about Pedi & Adolescent Care
      • 10 Ways Cannabis Supports Children’s Behavior
      • Children & Behavior Support
      • Safe Dosing for Kids
      • Complex Pediatric Care
    • Sponsor a Visit (Give a Gift of Care)
    • Discounts at CED
      • Lottery for a Free Consultation
      • Discounts, Coupons, and Free Consultations
      • Discounts at Dispensaries (MA)
    • GLP-1 Weight Management
    • Health Quiz: Are You Healthy?
  • Education
    • Practical Tips + Guidance
      • Travel With Cannabis
      • COA Guide & Lab Safety
      • Fixing Your Cannabis Tolerance
      • Why Cannabis Works
      • Smart Cannabis Dosing: Sweet Spot?
      • Cannabis Myths + Blind Spots
      • How to Talk to Your Doc about Cannabis
      • Slow Medicine: How Cannabis Heals Over Time
      • Why The War on Pot Rages
      • Feeling Too High?
      • Cannabis & Mental Health Truths
      • Cannabis Cough: The Basics
      • Science of The Cannabis Cough
      • What To Do: Feeling Too Racy
      • Weed Anxiety Explained: Paranoia, Panic & Relief
      • Why Aren’t Edibles Don't Work for You?
      • When to Pause
      • Cannabis Hyperemesis Syndrome (CHS): What to Know
    • Health & Wellness
      • Cannabis & Health (general)
      • Choosing Cannabis
      • Tips for Maximizing Effectiveness
      • Cannabis & Metabolism: Be Amazed!
      • Cannabis for Sleep
      • Cannabis for Stress
      • Cannabis for Pain
      • Topicals Guide
      • Future of Cannabis
    • Learn by Illness or Condition
      • Custom Cannabis Protocol
      • Mental Health & Neurological Disorders
      • ADHD: A Guide to Focus, Calm, and Control
      • Crohn’s and Gut Health: Relief Strategies
      • Gastrointestinal & Autoimmune Conditions
      • Dermatological & Skin Conditions
      • Chronic Pain & Inflammation
      • Women’s Health & Hormonal Conditions
      • Pregnancy & Cannabis, Explained
      • Sleep Disorders & Circadian Rhythm Issues
      • Pain Management with Cannabis
      • Autism & Behavior: Expert Guidance for Families
      • Post-Surgical & Injury Recovery
      • Substance Dependence & Withdrawal Support
    • Learn about Products
      • Types of Cannabis Sold
      • CBD Strength Guide
      • Cannabis Tolerance: Management
      • Topical Cannabis Products: Guide to Uses, Benefits & DIY
      • Unique Cannabinoids: Beyond THC & CBD
      • Vaporizing Cannabis: Safer, Effective Consumption
    • Best Ways To Take Cannabis
      • Cannabis FAQs (basic)
      • Start Here
      • Cannabis Therapy Guidance
      • Dosage & Usage Guide
      • Nebulized Cannabis Guide
      • Topicals & Lotions
      • Tinctures & Oils
      • Cannabis Edibles & Capsules
      • Inhalables & Vaporization
    • Educational Resources
      • Dr Caplan's Book Website
        • Personalized, Signed Copy
        • My Book (Amazon)
        • Each Book Dedication is Unique!
      • FAQ Encyclopedia
      • Dr Caplan's Classroom
        • Book Diagrams + CaplanCannabis Site (free)
        • Video Library
        • Handouts & Guides
        • AI Book Review
        • Spotify: Green Table Talk Podcast
        • YouTube
        • Dr Caplan's Book (Order Now - Amazon!)
      • Cannabis Basics Overview
      • The Problems Cannabis Helps Us Manage
      • Endocannabinoid System
      • Cannabis Science
      • CED Cannabis Literature Library
      • Patient Care & Findings
      • Patient Insights
    • Guide: How to Buy Cannabis Flower
    • FAQ (Cannabis Encyclopedia)
    • Popular Blogs: 2026
      • Long-Term Effects of Cannabis
      • Reset Your Cannabis Tolerance
      • Weed Anxiety Explained: A Doctor’s Guide to Paranoia, Panic & Relief
      • 5 Reasons CBD CBG Topicals For Eczema Care is Amazing
      • Cannabis for Sleep
      • Slow Medicine: How Cannabis Heals Over Time
      • Why Aren’t Edibles Working for You?
      • When Cannabis Might NOT Be Right for You
      • Women’s Health & Hormonal Conditions
      • Cannabis for Stress
      • Cannabis for ADHD: A Guide to Focus, Calm, and Control
      • Too High? What To Do
      • Moldy Marijuana: MA recalls moldy flower
    • CED Favorites
      • Video: Cannabis Tolerance Explained
      • Plant Nurition Explained
      • Light THC & CBD Picks
      • High-Potency Cannabis Guide
      • Sugar-Free Cannabis Options
      • Cannabis & Your Heart
      • Cannabis and Psychosis
      • Vaginal Suppositories Page
      • Rectal Suppositories Page
      • Medical Cannabis Crossroads
      • Cannabis and Heart Health
      • Is Weed Addictive? Dependence vs Addiction
      • Cannabis and Menopause
      • Cannabis & Aging
      • CBD & Liver Enzymes
      • How Cannabis Works Differently
      • Emergence: How Wholes Outthink Parts
      • Our New Post-Covid Baseline
    • Non-Cannabis Writing
      • Social Capacity vs Identity: Connection
      • AI in Medicine Explained
      • Tylenol & Autism Debate
      • Power of Clicks and Likes
      • Rethinking Diagnosis in Kids
  • Partner with Dr Caplan
    • Partner on Education & Research
    • Work with Dr Caplan
    • Media Inquiries
    • Interview Dr. Caplan
    • Book Dr. Caplan to Speak
    • Clinical Cannabis Education Program
    • Modular (Custom) Professional Education
    • Volunteer at CED (Social Impact Work)
    • Cannabis Business Consulting
    • Building Big Data
    • Promote With CED Clinic
  • Resources, Supplies, Events
    • Share YOUR Story
    • Trusted Resources & Products
    • Shop Products: Gummies, Drinks, Oils, Flower...
    • Handmade Glass
    • Myriams CBD
    • Outside Resources
    • Past Events
    • Dispensary Highlights
    • Fireside Chats
Subscribe
Close

Search

Exclusive
Real-Time Monitoring of Youth Substance Use: A New Preprint Review | ecological momentary assessment substance use
August 20, 2026
Real-Time Monitoring of Youth Substance Use: What a New Preprint Review of 43 Studies Found
Brain region-specific and sex-dependent roles of 2-arachidonoylglycerol in the retrieval of ...
August 20, 2026
Brain region-specific and sex-dependent roles of 2-arachidonoylglycerol in the retrieval of …
Cannabis use disorder rising among US adults, study finds - NBC 15
August 20, 2026
Cannabis use disorder rising among US adults, study finds – NBC 15
Cannabis use disorder rising among US adults, study finds
August 20, 2026
Cannabis use disorder rising among US adults, study finds
Marijuana's menace: cannabis use disorder spiking, study says
August 20, 2026
Marijuana’s menace: cannabis use disorder spiking, study says
A Look at More Than 30 Cannabis and Cannabinoid Clinical Trials Published in 2026
August 20, 2026
A Look at More Than 30 Cannabis and Cannabinoid Clinical Trials Published in 2026
cannabis peach oat crumble finished recipe styled as the emotional anchor with warm editorial food photography
August 20, 2026
Cannabis Peach Oat Crumble Recipe
Canada's New Cannabis Brain Health Research Consortium
August 20, 2026
Canada’s New Cannabis Brain Health Research Consortium
Government of Canada investing $24 million to establish cannabis and brain health ...
August 20, 2026
Government of Canada investing $24 million to establish cannabis and brain health …
Healing without the High: Elizabeth Mack, RN on the Power of Cannabino - Dr. Clark Store
August 20, 2026
Healing without the High: Elizabeth Mack, RN on the Power of Cannabino – Dr. Clark Store
Medicinal cannabis prescriptions surge to more than 72,000 in a year
August 20, 2026
Medicinal cannabis prescriptions surge to more than 72,000 in a year
PleoPharma Awarded $6.5 Million NIDA Grant to Support Phase 3 Trial of PP-01 for ...
August 20, 2026
PleoPharma Awarded $6.5 Million NIDA Grant to Support Phase 3 Trial of PP-01 for …
GLP-1 SGLT2 Combination Cardiorenal Outcomes | Evidence Report
August 20, 2026
GLP-1 Plus SGLT2 Therapy: What an Exploratory Cardiorenal Meta-Analysis Found
Neutral laboratory glassware representing cannabinoid product testing
August 20, 2026
Ireland Finds High-Risk Synthetic Cannabinoids in CBD and Cannabis Products
Dulaglutide vs Insulin in Thalassaemia Diabetes Trial | dulaglutide thalassaemia diabetes trial
August 20, 2026
Dulaglutide vs Insulin in Adolescents With Thalassaemia-Related Diabetes
What are the health risks from synthetic cannabinoids?
August 20, 2026
What are the health risks from synthetic cannabinoids?
Virginia family fears new hemp law will cut off daughter's longtime seizure treatment
August 20, 2026
Virginia family fears new hemp law will cut off daughter’s longtime seizure treatment
Study Finds CBD Improves Social Deficits, Hyperactivity and Repetitive Behaviors in Autism Model
August 20, 2026
Study Finds CBD Improves Social Deficits, Hyperactivity and Repetitive Behaviors in Autism Model
Does Cannabis Lower Blood Sugar *Nkzlj1NKw*
August 20, 2026
Does Cannabis Lower Blood Sugar *Nkzlj1NKw*
Cannabinoids in Sleep and Sleep Disorders: S9-Ep1
August 20, 2026
Cannabinoids in Sleep and Sleep Disorders: S9-Ep1
Daily Cannabis News Brief for 8/18/2026
August 19, 2026
Daily Cannabis News Brief for 8/18/2026
New Reviews Highlight the Endocannabinoid System as a Promising Frontier in Migraine ...
August 19, 2026
New Reviews Highlight the Endocannabinoid System as a Promising Frontier in Migraine …
NYU study shows diverse cannabis use patterns signal heavier use - News-Medical
August 19, 2026
NYU study shows diverse cannabis use patterns signal heavier use – News-Medical
USPS to roll back ban and deliver brand new item for the first time to Americans in US state ...
August 19, 2026
USPS to roll back ban and deliver brand new item for the first time to Americans in US state …
IMG 2201 copy 18
August 19, 2026
Inhaled cannabis reduces number of daily ectopic heart beats
Cannabis linked to earlier onset of psychosis
August 19, 2026
Cannabis linked to earlier onset of psychosis
Glucocorticoid–endocannabinoid crosstalk in the ventrolateral periaqueductal gray (vlPAG ...
August 19, 2026
Glucocorticoid–endocannabinoid crosstalk in the ventrolateral periaqueductal gray (vlPAG …
Medical Marijuana Improves Sleep Satisfaction And Boosts Quality Of Life, Study Shows
August 19, 2026
Medical Marijuana Improves Sleep Satisfaction And Boosts Quality Of Life, Study Shows
School is back in session! THC % matters—but it's not the whole story. Cannabis ...
August 19, 2026
School is back in session! THC % matters—but it’s not the whole story. Cannabis …
Terpenes Explained: Cannabis Flavors & Effects in NJ
August 19, 2026
Terpenes Explained: Cannabis Flavors & Effects in NJ
CBD shows potential to broadly affect leukaemia cells by boosting immune responses ...
August 19, 2026
CBD shows potential to broadly affect leukaemia cells by boosting immune responses …
Home/Cannabis Science/Real-Time Monitoring of Youth Substance Use: What a New Preprint Review of 43 Studies Found
Real-Time Monitoring of Youth Substance Use: A New Preprint Review | ecological momentary assessment substance use
Cannabis Science

Real-Time Monitoring of Youth Substance Use: What a New Preprint Review of 43 Studies Found

By Benjamin Caplan, MD
16 Min Read
Comments Off on Real-Time Monitoring of Youth Substance Use: What a New Preprint Review of 43 Studies Found
CED Clinical Relevance #78 Clinical Evidence Update A systematic narrative review pooling 43 studies is the first synthesis focused specifically on ecological momentary assessment and intervention tools for substance use, including cannabis, among youth in clinical settings. Its scope and organized six-domain framework place it at the newsjack threshold, but it remains a preprint that has not yet completed peer review, which keeps its score at the qualifying line rather than higher.
Clinical Insight | CED Clinic
Clinicians who treat adolescents and young adults for cannabis or other substance use know that a single clinic visit captures only a narrow slice of a teen’s actual pattern of use, the moments of craving, the social settings, the emotional states that precede an episode. Ecological momentary assessment, brief smartphone-based check-ins delivered several times a day, offers a way to see substance use as it unfolds in real time rather than relying on a patient’s memory weeks or months later. A newly posted systematic review pulls together this work for the first time with a specific focus on youth in clinical settings, and finds real signal, alongside real gaps that keep this evidence at an early stage.
Adolescent MedicineDigital HealthSystematic ReviewSubstance UsePreprint
AudienceClinicians treating adolescents and young adults in emergency, primary care, mental health, or substance use treatment settings, parents of teens using cannabis or alcohol, and researchers interested in real-time digital monitoring tools for youth substance use
Primary TopicA systematic narrative review of 43 studies testing ecological momentary assessment (EMA) and ecological momentary intervention (EMI) tools for tracking and addressing substance use, including cannabis, among youth in clinical settings, posted as a preprint on Research Square in July 2026
SourceRead the preprint on Research Square

Table of Contents

  • Real-Time Monitoring of Youth Substance Use: What a New Preprint Review of 43 Studies Found
    • How to Read a Preprint Review Before the Peer-Reviewed Version Exists
      • A Four-Step Reading Frame
    • The Same Study Can Mean Different Things Depending on the Question Being Asked
        • Promising Direction, Not a Ready-to-Use Tool
        • A First Map of Real-Time Predictors in Youth Clinical Populations
        • Preprint Status Is the First Fact, Not a Footnote
        • A Reminder to Ask About Context, Not Just Frequency
        • A Narrative Review Without Pooled Estimates
        • Passive Sensing Signals a Path Toward Lower-Burden Tools
        • Accurate Framing Matters for an Unreviewed Preprint
        • A Direct Case for Peer Review and Larger Trials
    • Frequently Asked Questions
  • Newsletter Signup Form
      • Read next
      • Related

Real-Time Monitoring of Youth Substance Use: What a New Preprint Review of 43 Studies Found

Talk to Dr. Caplan

Want to apply this research to your own care?

30,000+ patients treated. Appointments in Massachusetts and via telemedicine.

Book a consultation →GLP-1 + cannabis program
BC

Dr. Benjamin Caplan, MD

Board-certified Family Medicine

20+ years in cannabis medicine. CMO, CED Clinic. Author, Penguin Random House. Principal Investigator in multiple studies.

Full bio →

Related reading

  • Conditions A–Z →
  • Cannabis & anxiety →
  • Cannabis & sleep →
  • Cannabinoid profiles →

Wherever you are

Dr. Caplan offers consultations for complex conditions and wellness needs. Patients from across the US and internationally are welcome.

Book a consultation →

A systematic narrative review pulled together 43 studies testing real-time, smartphone-based monitoring and intervention tools for substance use, including cannabis, alcohol, and nicotine, in adolescents and young adults treated in emergency, medical, mental health, and substance use settings. The approach shows real promise for catching risk moments as they happen, but the review itself is a preprint that has not yet completed peer review.

What This Study Teaches Us
This review maps out what real-time monitoring has taught researchers about youth substance use so far, the specific moments, negative affect, evening hours, weekends, being around friends, and prior use itself, that most consistently precede substance use in daily life, and shows that a small but growing set of real-time interventions built on this monitoring can reduce substance use harms. It also teaches how early-stage this science still is, both because it is a preprint and because the underlying studies vary widely in method and quality.
Why This Matters
Adolescents and young adults are exactly the population where clinic-based screening tools most often miss what is actually happening day to day. A tool that can flag a high-risk moment, a stressful evening, a specific social setting, in real time, and deliver support at that moment rather than at the next scheduled visit, could meaningfully change how clinicians support teens at risk for escalating cannabis, alcohol, or nicotine use. This review is the first to bring together the evidence on these tools specifically for youth in clinical settings, emergency departments, primary care, mental health programs, and substance use treatment programs, giving clinicians a first look at where this approach stands and where it still falls short.
Study Snapshot
Study TypeSystematic narrative review (not yet peer-reviewed; posted as a preprint on Research Square)
Peer Review StatusPreprint only. Posted July 30, 2026. Has not completed journal peer review at the time of this writing.
PopulationYouth in clinical settings, mean or median age 25 or younger, across emergency, medical, mental health, and substance use treatment settings
Databases SearchedPsycInfo, MEDLINE, and Scopus
Screening12,093 titles and abstracts screened; 2,157 full texts reviewed
Studies Included43 studies representing 24 unique monitoring or intervention protocols (15 observational, 9 intervention)
Substances StudiedAlcohol (75% of protocols), cannabis (67%), and nicotine or tobacco (33%)
Typical EMA Protocol14 days of monitoring with 4 prompts per day; 3 protocols added passive biosensing
Data Captured270 momentary antecedents and 17 momentary consequences of substance use, organized into six domains
Most Consistent PredictorsNegative affect, situational context (evenings, weekends, being with friends), and prior substance use, though findings were heterogeneous across studies
Interventions Tested13 real-time interventions combining monitoring with feedback, goal-setting, or coping support, associated with reduced substance use harms
Authors10 total authors, led by Jillian Halladay, with James MacKillop as the final listed author
Journal / ServerResearch Square (preprint server)
PostedJuly 30, 2026
DOI10.21203/rs.3.rs-10525385/v1
PMID42619989
Clinical Bottom Line
A first-of-its-kind review pooling 43 studies found that real-time, smartphone-based monitoring can reliably flag the moments, negative mood, evenings, weekends, being with friends, and prior use itself, that precede substance use in youth, and that a small set of real-time interventions built on this monitoring appears to reduce use-related harms. The review itself, however, is a preprint that has not yet been peer-reviewed, and the underlying studies are described by the authors themselves as methodologically heterogeneous.
What the Review Searched For

Researchers searched PsycInfo, MEDLINE, and Scopus for studies using ecological momentary assessment (EMA) or ecological momentary intervention (EMI) methods to measure or address substance use among youth, defined as a mean or median sample age of 25 or younger, in clinical settings. Eligible settings included emergency departments, general medical care, mental health services, and substance use treatment programs.

From 12,093 titles and abstracts screened and 2,157 full texts reviewed, the review ultimately included 43 published studies representing 24 unique monitoring or intervention protocols. Fifteen protocols were purely observational, tracking substance use patterns without intervening, and nine tested an active real-time intervention.

Cannabis Was One of Three Most-Studied Substances

Across the 24 protocols, alcohol was the most frequently studied substance (75%), followed closely by cannabis (67%) and nicotine or tobacco (33%). Many protocols tracked more than one substance simultaneously, reflecting the reality that polysubstance use is common among the youth populations studied.

The typical EMA protocol asked participants to complete brief check-ins for 14 days, with four prompts delivered per day, a burden low enough to sustain the two weeks needed to capture meaningful patterns. Three protocols went further, adding passive biosensing, wearable or phone-based sensors that track physiological or behavioral signals, without requiring the participant to actively respond.

What Real-Time Data Revealed About Risk Moments

The included studies captured 270 distinct momentary antecedents (factors that came before substance use) and 17 momentary consequences (effects that followed it), organized by the reviewers into six domains: substance use itself, affect and cognition, environmental context, social context, movement or physical activity factors, and how consistently participants completed their EMA prompts.

Three factors showed the most consistent association with substance use across studies: negative affect (feeling stressed, anxious, or low), situational context such as evenings, weekends, or being around friends, and prior substance use earlier in the same monitoring period. The review’s authors describe the overall findings as heterogeneous, meaning the strength and even the direction of some associations varied across studies.

Real-Time Interventions Showed Early Promise

Beyond monitoring alone, the review identified 13 evaluated interventions that layered a real-time response, feedback about a person’s own reported use, goal-setting prompts, or coping-skill support, on top of ecological momentary monitoring. These interventions were associated with reductions in substance use-related harms in the included studies.

The review also notes that passive sensing approaches, the wearable or phone-based tools that do not require active participant input, demonstrated strong predictive performance in the studies that used them, a signal that these tools may eventually reduce the burden of frequent active check-ins.

This Is a Preprint, Not a Peer-Reviewed Publication

This review was posted to Research Square, a preprint server, on July 30, 2026, and carries PubMed identifier 42619989 with the article type listed as “Journal Article, Preprint.” It has not yet completed formal peer review or been accepted by a journal at the time of this writing.

Readers, and clinicians in particular, should weigh this review’s findings with that status clearly in mind. Preprints allow findings to circulate faster, but they have not yet been vetted by independent expert reviewers, and the specific conclusions, methods, and data reported here could change before, or if, this work is formally published.

How Strong Is This Evidence?
The review’s greatest strength is its scope: it appears to be the first systematic attempt to pull together the ecological momentary assessment and intervention literature specifically for youth substance use across clinical settings, rather than general population samples. A three-database search strategy (PsycInfo, MEDLINE, Scopus), a large initial screening pool of over 12,000 records, and an organized six-domain framework for classifying momentary antecedents and consequences give the synthesis real structure. The finding that passive sensing tools showed strong predictive performance, and that a meaningful subset of real-time interventions were associated with reduced substance use harms, offers a concrete, testable direction for future clinical tools.
Where This Paper Deserves Skepticism
The most important caveat is procedural rather than statistical: this is a preprint that has not yet undergone peer review, so its methods, data extraction, and conclusions have not yet been independently verified by outside experts, and the article itself is subject to revision or correction. The authors also describe their own evidence base as methodologically heterogeneous, meaning study designs, sample sizes, EMA protocols, and outcome definitions varied considerably across the 43 included studies, which limits how confidently any single association, such as negative affect preceding use, can be generalized. This is a narrative systematic review rather than a meta-analysis, so no pooled effect sizes or confidence intervals are reported to quantify the strength of any individual finding. Finally, the review spans a broad range of clinical settings and youth ages up to 25, and it is not possible from the summary available here to determine how findings specific to cannabis use compare with those for alcohol or nicotine.
What This Paper Does Not Show
This review does not show that any specific ecological momentary intervention is ready for routine clinical deployment; the 13 evaluated interventions varied in design, and the review does not report a single validated protocol that clinicians could adopt today. It does not provide a pooled estimate of how much real-time monitoring or intervention reduces cannabis use specifically, since cannabis was one of several substances tracked across the included protocols rather than the sole focus. It does not establish that passive biosensing tools are ready to replace active self-report check-ins in clinical care, despite showing strong predictive performance in a small number of studies. And because this is a preprint, it does not represent a peer-reviewed, journal-vetted conclusion; that step has not yet occurred.
How This Fits With the Broader Clinical Conversation

Interest in digital phenotyping and real-time monitoring for substance use has grown alongside the broader adoption of smartphones and wearable sensors in clinical research, offering a way to study behavior as it happens rather than reconstructed from memory during a clinic visit or research interview.

This review adds to that broader movement by focusing specifically on youth, a population where substance use screening in traditional clinical encounters is known to be imperfect, and where the treatment settings, emergency care, mental health services, and substance use programs, represent moments when clinicians have a real opportunity to intervene early.

Dr. Caplan’s Take

I welcome any serious attempt to understand cannabis and other substance use in young people as it actually happens, rather than through the imperfect lens of a single clinic visit and a patient’s memory of the weeks before. The pattern this review surfaces, that negative mood, specific situational triggers, and prior use itself are the most consistent predictors of subsequent use, matches a great deal of what I hear directly from young patients and their families.

That said, I want to be plain about where this evidence currently stands. This is a preprint. It has not yet been peer-reviewed, and I am treating its specific findings as an early, exploratory signal rather than settled science. I am genuinely encouraged by the direction, real-time tools that can catch a risk moment and respond to it, but I would not recommend a specific app, protocol, or intervention to a patient or family based on this review alone. I will be watching for the peer-reviewed version of this work, and for the larger, better-powered trials the field still needs, before drawing firmer clinical conclusions.

What a Careful Reader Should Take Away
A preprint systematic review of 43 studies found that real-time, smartphone-based monitoring can reliably identify the moments, negative mood, evenings, weekends, social settings, and prior use, that precede substance use in youth, including cannabis use, and that a small set of real-time interventions built on this approach showed promise for reducing use-related harms. This is an early, not-yet-peer-reviewed signal pointing toward a promising direction for future clinical tools, not a validated intervention ready for practice.
Evidence Interpretation Guide

How to Read a Preprint Review Before the Peer-Reviewed Version Exists

A systematic review pooling 43 studies and describing specific real-time predictors of substance use can sound like settled clinical guidance.

Four checks keep this preprint’s real, still-developing contribution in view.

A Four-Step Reading Frame

Check the peer-review status first
This review is a preprint posted on Research Square and has not yet completed independent peer review or journal publication.

Note the review type
This is a narrative systematic review, not a meta-analysis, so no pooled effect size quantifies how strong any single predictor or intervention effect actually is.

Separate monitoring findings from intervention findings
Most of the review’s data describes what real-time monitoring detected, 270 antecedents and 17 consequences, while only 13 of the 24 protocols tested an actual intervention.

Hold the authors' own caveat
The authors describe the evidence as exploratory and methodologically heterogeneous, and call for more methodological transparency and rigor in future studies.

The Research Question
Can ecological momentary assessment and intervention tools reliably detect and reduce substance use, including cannabis use, among youth treated in clinical settings?
The Family Question
Could a real-time monitoring app or program help identify and respond to risk moments for my teen’s substance use before it develops into a bigger problem?
The Bottom Line
Early, preprint evidence suggests real-time monitoring can identify meaningful risk moments and that some real-time interventions may help, but this has not yet been peer-reviewed or validated well enough to recommend a specific tool or protocol in clinical practice.
CED Perspective Lens

The Same Study Can Mean Different Things Depending on the Question Being Asked

Scientific papers rarely answer a single question. Patients, clinicians, researchers, policymakers, and critics often read the same data differently. The perspectives below explore how this study looks through several evidence-based lenses.

Lens Overview
Eight perspectives keep a preprint review of 43 studies from being oversold as a validated clinical tool, or dismissed because it has not yet completed peer review.

Promising Direction, Not a Ready-to-Use Tool

If your teen is using cannabis, alcohol, or nicotine, this review suggests that real-time monitoring tools, the kind built into some smartphone apps, may eventually help identify the specific moments and situations that put them at risk.

This is early, not-yet-peer-reviewed research. No single app or program studied here has been shown to be ready for widespread clinical use, so ask your clinician before relying on any specific commercial product marketed this way.

Lens takeaway
Treat this as a promising research direction to watch, not a validated tool to adopt today.

A First Map of Real-Time Predictors in Youth Clinical Populations

For clinicians treating youth substance use, this review’s six-domain framework, substance use, affect and cognition, environmental context, social context, movement factors, and EMA compliance, offers a useful organizing structure for thinking about what drives use outside the clinic walls.

The consistency of negative affect and specific situational triggers across studies lines up with established clinical intuition, but the review’s preprint status and methodological heterogeneity mean it should inform hypothesis generation rather than immediate practice change.

Lens takeaway
Useful for framing clinical conversations about triggers, not yet a basis for adopting a specific monitoring protocol.

Preprint Status Is the First Fact, Not a Footnote

Before engaging with any of this review’s specific findings, its most important characteristic is that it has not been peer-reviewed. The methods, data extraction, and conclusions have not yet been independently checked by outside experts.

The review also synthesizes 43 studies that the authors themselves describe as methodologically heterogeneous, without a pooled effect size, which limits how much weight any single reported association should carry until stronger, peer-reviewed synthesis exists.

Lens takeaway
Read this as an early signal awaiting peer review, not as an established evidence base.

A Reminder to Ask About Context, Not Just Frequency

Primary care clinicians screening adolescents and young adults for substance use often ask about frequency and quantity. This review’s findings point toward context, mood state, time of week, and social setting, as equally important pieces of the picture.

Even without a specific validated app to recommend, clinicians can use this framework to ask more targeted questions about what mood, setting, or company tends to precede a young patient’s use.

Lens takeaway
A useful conversational framework today, even before any specific digital tool is validated.

A Narrative Review Without Pooled Estimates

This is a systematic narrative review, not a meta-analysis, so there are no pooled effect sizes or confidence intervals quantifying how strongly, for example, negative affect predicts subsequent substance use across the included studies.

Classifying 270 antecedents and 17 consequences into six domains involved reviewer judgment, and the review does not report how consistently different reviewers agreed on those classifications in the abstract summary available here.

Lens takeaway
A useful organizing synthesis with real limits on quantitative precision, further limited by its preprint status.

Passive Sensing Signals a Path Toward Lower-Burden Tools

The finding that passive biosensing protocols, those using wearable or phone-based sensors rather than active check-ins, showed strong predictive performance is notable for anyone building lower-burden monitoring tools for youth.

Only three of the 24 included protocols used passive sensing, so this remains an early signal rather than a mature technology ready for clinical deployment.

Lens takeaway
Passive sensing is a direction worth watching, not yet a proven replacement for active monitoring.

Accurate Framing Matters for an Unreviewed Preprint

Headlines simplifying this preprint into an app that predicts and prevents teen drug use would overstate a review whose interventions were tested in only 9 of 24 protocols and which has not yet been peer-reviewed.

For a population already navigating stigma around substance use, accurate communication about what this early evidence does and does not yet establish protects both patients and the credibility of the underlying research.

Lens takeaway
Report the preprint status and the monitoring-versus-intervention distinction accurately, not as a finished clinical breakthrough.

A Direct Case for Peer Review and Larger Trials

The authors’ own call for greater methodological transparency and rigor is a specific, actionable research priority, and the fact that this synthesis exists at all creates a template that future, better-powered studies can build on.

Given how common cannabis and alcohol use are among the youth populations described here, funding the rigorous, peer-reviewed intervention trials this review points toward is a reasonable next step for research investment.

Lens takeaway
This preprint makes the case for the peer-reviewed, adequately powered trials that should follow it.

Join the Conversation

Have a question about how this applies to your situation? Ask Dr. Caplan

Want to discuss this topic with other patients and caregivers? Join the forum discussion

CED Clinic logo
Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.
Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance
Leave a Message Metabolic Care Medical Consulting Cannabis Care
Dr. Benjamin Caplan
Share this Evidence Watch
X LinkedIn BlueSky Instagram Substack RSS
Source: Halladay J, Hira V, Gex K, Meisel S, Bryant Z, Wilson J, Stockings E, Slade T, McDonald A, MacKillop J. Ecological momentary assessments and interventions for youth substance use across clinical settings: A systematic review. Research Square. Preprint posted July 30, 2026. DOI: 10.21203/rs.3.rs-10525385/v1. PMID: 42619989.
Related Reading at CED Clinic
Continue exploring the evidence
Adolescent Cannabis Use and Its Impact on Cognitive Development: Insights from the ABCD Study

A CED review of ABCD Study findings on how adolescent cannabis use affects memory, attention, and executive function, useful context for why real-time monitoring of youth cannabis use matters clinically.

Read the ABCD Study review
Can a Text-Message Intervention Reduce Cannabis-Impaired Driving? A New Randomized Trial

A CED look at a randomized trial testing a real-time, text-message-based intervention for cannabis-impaired driving in emerging adults, a direct example of the kind of ecological momentary intervention this review synthesizes.

Read the text-intervention trial review
Virtual Program Reduces Cannabis and Alcohol Use in Native American Emerging Adults

A CED review of a randomized trial testing a culturally grounded virtual intervention for cannabis and alcohol use in emerging adults, relevant background on digital and virtual approaches to youth substance use treatment.

Read the virtual intervention trial review

Frequently Asked Questions

What is ecological momentary assessment (EMA)?

Ecological momentary assessment is a research method that asks participants to complete brief check-ins, often several times a day through a smartphone, about their current mood, environment, and behavior, including substance use, in real time rather than relying on memory during a later clinic visit or interview.

What did this review look at?

A systematic narrative review searched PsycInfo, MEDLINE, and Scopus for studies using EMA or ecological momentary intervention (EMI) methods to measure or address substance use among youth, mean or median age 25 or younger, in emergency, medical, mental health, or substance use treatment settings. It included 43 studies representing 24 unique protocols.

Was cannabis specifically studied?

Yes. Cannabis was tracked in 67% of the 24 included protocols, making it the second most frequently studied substance after alcohol (75%) and ahead of nicotine or tobacco (33%). Many protocols tracked more than one substance.

What factors most consistently preceded substance use in the studies?

Negative affect, such as stress, anxiety, or low mood, situational context such as evenings, weekends, or being with friends, and prior substance use earlier in the monitoring period showed the most consistent associations with subsequent use, though the authors describe the overall findings as heterogeneous.

Did any real-time interventions work?

The review identified 13 evaluated interventions that combined real-time monitoring with feedback, goal-setting, or coping support, and these were associated with reductions in substance use-related harms in the included studies. No single intervention protocol was identified as ready for routine clinical use.

What is passive biosensing, and how well did it work?

Passive biosensing uses wearable or phone-based sensors to track physiological or behavioral signals without requiring the participant to actively respond to a prompt. Only three of the 24 protocols used passive sensing, but those approaches showed strong predictive performance in the included studies.

Is this review peer-reviewed?

No. This review was posted to Research Square, a preprint server, on July 30, 2026, and its PubMed record lists the article type as "Journal Article, Preprint." It has not yet completed formal peer review or been accepted by a journal.

Is this a meta-analysis?

No. This is a systematic narrative review, not a meta-analysis, so it does not report pooled effect sizes or confidence intervals quantifying the strength of any individual predictor or intervention effect.

What does this review not show?

It does not show that any single ecological momentary intervention is ready for routine clinical deployment, does not provide a pooled estimate of effect specific to cannabis use, and does not establish passive sensing as a replacement for active self-report monitoring. Because it is a preprint, it also does not represent a peer-reviewed, journal-vetted conclusion.

What should clinicians and families take from this?

This preprint review points to a promising research direction, real-time tools that can identify risk moments and respond with support, for youth substance use, including cannabis use. Given its preprint status and the heterogeneity of the underlying studies, it should be treated as an early signal rather than a basis for adopting a specific clinical tool today.

  • Newsletter Signup Form

    Enter your email address to subscribe to our newsletter.
  • Should be Empty:

Read next

GLP-1 Plus SGLT2 Therapy: What an Exploratory Cardiorenal Meta-Analysis Found

Related

Tags:

Adolescent MedicineDigital Healthdigital health substance use benefits risks limitationsecological momentary assessment substance useecological momentary assessment substance use evidence reportyouth cannabis use monitoring clinical implications
Author

Benjamin Caplan, MD

Follow Me
Other Articles
Brain region-specific and sex-dependent roles of 2-arachidonoylglycerol in the retrieval of ...
Previous

Brain region-specific and sex-dependent roles of 2-arachidonoylglycerol in the retrieval of …

Book Now Intake Form
Dr. Benjamin Caplan, MD Learn About Dr. Caplan
Copyright 2026 — CED Clinic. All rights reserved.

Questions about this research?

Talk to Dr. Caplan →
CED Clinic
CED Clinic Home
Explore
Cannabis Science
Research & Clinical
Cannabis News
Policy, Humor & News
Metabolic Health
GLP-1 Care & Science
Cannabis Recipes
Infused Foods & Drinks
Book an Appointment Contact CED Clinic
Recent Posts
Loading…
MENU